• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » MassDevice Q&A: OmniGuide chairman Yoel Fink

MassDevice Q&A: OmniGuide chairman Yoel Fink

June 1, 2010 By Christian Holland

When Yoel Fink began his groundbreaking work with mirrors at MIT in the late 1990’s, he didn’t know he would be creating a material that would be used to carry lasers into areas as hard to reach as the inner ear or brain. He was working on a problem that the Defense Advanced Research Projects Agency, the research and development arm of the U.S. military, wanted solved. For reasons still unknown to Fink, DARPA wanted large-area, low-cost surfaces more reflective than a mirror that could reflect light from all angles. Eventually, his work led to a PhD thesis and OmniGuide, the company where he is currently chairman. OmniGuide, which employs 120 workers, just last week celebrated its 10th year of business.

Since commercializing its technology in late 2006, the company’s product lines have enabled it to grow steadily. OmniGuide last year raised $1.84 million in equity financing, on top of a $25 million private equity round from the previous year, which the company used to develop new fibers indicated for different clinical applications in laser microsurgery. Late last year, the company won a half-million dollar tax break from the quasi-public Mass. Life Sciences Center to aid in job creation.

From his attempt to create large reflective surfaces, Fink was able to create what are essentially tiny pipes or hoses lined with what his research team at MIT called “perfect mirrors.” The mirrors that DARPA wanted to coat what Fink speculates were aircraft, or even aircraft carriers, are now lining the inside of tiny, hollow tubes that OmniGuide creates, in-house, to lengths of several kilometers at a time.

“We’re manufacturing products here that are really highly sophisticated and are technologically advanced. In fact we’re producing structures that companies like Intel would build in multi-billion dollar fabs, but we’re able to do it inside of fiber,” Fink said.

Photons from a CO2 laser glide through the hollow core of these fibers, called BeamPath technology. Unlike other laser products, the hollow core means there is no medium through which the laser must travel, increasing the length of light wavelengths that the fibers can transfer and therefore the type and precision of the device’s surgical applications. The photons are emitted by a device that OmniGuide calls a flexible laser scalpel, which is not a misnomer. The beam emitted by an OmniGuide laser is only 10s of microns thick and Fink’s optical technology enables the lasers to be sent through conduits as thin as heavy fishing line, into areas of the body not typically reachable by anything other than highly invasive surgery.

Currently neurosurgeons cut brain tissue using bipolar cautery to create an avascular line, then use scissors or a scalpel to cut between it. The most precise technology available has a lateral thermal spread of millimeters. Vice president of clinical affairs and business development Dr. Yair Schindel said that doesn’t make sense.

“When you think of soft tissue and ablation tools, everybody prides themselves minimal collateral damage,” but “[with OmniGuide lasers], we’re talking about 10s of microns, so you’re actually two orders of magnitude more precise than the most precise soft-tissue cutting tool out there today. That’s really where, if you had to crystallize the value proposition and what we bring is, in terms of precision microsurgery, there is nothing more precise than this that offer bloodless surgery.”

CO2 laser light stops at any surface it comes into contact with, cutting and cauterizing a layer of tissue only a few micrometers thick. OmniGuide’s laser scalpel is so precise because “water is a shield,” Schindel said, “and surgeons love that,” because the human body is about 60 percent water.

“If [surgeons] want to protect a certain area, all they need to do is take a wet cotton wipe or just a drop of saline and they have the ultimate shield.”

OmniGuide

OmniGuide laser implements are designed for specific surgical procedures.
Photos by Connor Gleason

MassDevice spoke with OmniGuide’s Yoel Fink and Yair Schindel about their company’s business development strategy.

MassDevice: How did making mirrors for the military turn into a surgical laser business?

Yoel Fink: The company, when it started, had lots of dreams about what you could do if you could solve the problem of manufacturing and making [what DARPA wanted], but at the end of the day, it was very clear to us that before we knew how to make this stuff, there was no markets to be had. It was only in 2002 after the papers that described the process [to create the material] came out of MIT that the company finally had a license to the technology and that got us thinking about practical problems we could solve. One problem we could solve was that of the guidance of CO2 laser light, which has a wavelength that does not allow it to pass through any materials, so it has to be guided by some other mechanism, and that’s where we started the commercialization process realized that the CO2 is prominently featured in precision microsurgery. That became our key application: Cutting precisely with light, producing optical scalpels that are more precise than anything out there. The key value is that we can cut at a distance and perform surgeries that are minimally invasive. Our technology is used in 1,000 surgeries a month. Four hundred of those are in ontology, 400 are in airway tumor management and the rest are a combination of neurosurgery, spine and some additional markets such as gynecology.

MassDevice: What enabled your latest product release?

YF: For the latest release, two things came together. One was a large scale clinical trial in Causse Ear Clinic in France, that demonstrated superior outcomes in using our fiber versus an incumbent technology. It showed that by using a fiber, you could improve hearing results after a procedure called stapedectomy. That was very exciting for us because it showed on a statistically significant level that patients using our technology have better outcomes. The second thing is that we introduced yet another generation of products into that market that were better, based on surgeon feedback.

Our business model is that of disposable fibers and disposable scalpels, so we have a laser unit that is reusable, hand pieces that are reusable, but the fibers are disposable. What we do is that we have fibers that are optimized for particular surgical applications. If you think about a knife, you think about it as a generic product. In terms of surgery, knives and scalpels delivery different levels of value for different procedures. If someone needs to have a brain tumor removed or a tonsil removed, there is a different value created for each procedure. Our scalpels are designed and optimized for delivering the maximal level of value per procedure. We haven’t done it for all procedures and in some cases we have just a number of products per market, but we’re aiming to optimize the fiber for procedure.

Yoel Fink

OmniGuide chairman and founder Yoel Fink.
Photos by Connor Gleason

MassDevice: Does your work on the structure of the fibers themselves lend to that optimization?

YF: That’s exactly it. Why would we want to both design and manufacture? That fact that we’re vertically integrated — which is that we receive elements from the periodic table into our [Kendall Square, Cambridge building] and out comes surgical outcomes by the time the product reaches the surgeon and he performs the surgery — gives you an amazing ability to take feedback from the market, condense it down to engineering guidelines and principals, use that to drive your development cycle, and close that loop and on a very frequent basis. That’s something that we feel very strongly about and I think it’s one of the strengths of the company. Our sales organization is 50-strong and they’re doing cases every day. From those cases we get a lot of information about what our fibers are doing well and some of the things they’re not. We take that information, it goes into a feedback loop and out comes a new product. Our new otology product came out of a process like that. People used our [gentube] and said certain modifications would make it better and because we were manufacturing and engineering it we could close out very rapidly.

OmniGuide

An OmniGuide laser scalpel.
Connor Gleason

MassDevice: What’s next for OmniGuide?

Yair Schindel: [The markets for OmniGuide’s line of lasers] are growing fast. There’s also an ongoing international expansion in Europe and Asia, and we’re already CE Mark approved in Europe. Within clinical development at our office in Kendall Square, we’re also looking at urology for prostate cancer, gastroenterology for intestinal cancer, ophthalmology and gynecology. Really the challenge for OmniGuide, since we do have clinical value in many of these different places, is not to bite off more than we can chew and be the best that we can in a few segments. The clinical potential – the business potential – is also still out there for us. In precision microsurgery, the more technologies are advancing, the more we can see better. Imagine being able to combine the stability of a robot, with the excellent visuals that they have, with the most precise tip of the spear.

Filed Under: Business/Financial News, Dental Tagged With: MassDevice Q&A, OmniGuide

In case you missed it

  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • Enovis partners with Kelvi on hot and cold therapies
  • West Pharmaceutical Services debuts new needle syringe system
  • Titan Medical names Cary G. Vance as new president, CEO
  • Acutus completes first closing in left-heart access portfolio sale to Medtronic
  • FDA clears Intuitive, Siemens Healthineers imaging integration for robotic bronchoscopy
  • FDA backs COVID-19 boosters with BA.4/5 spike proteins for fall
  • How safe is health information after the overturning of Roe?
  • Smith+Nephew opens new plant in Malaysia
  • BD launches combination COVID-19, flu, RSV diagnostic test
  • Zimmer Biomet creates independent nonprofit organization to reduce health disparities
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
  • Nasdaq grants Titan Medical 180-day extension to regain compliance
  • Aerin Medical reports positive 4-year results for VivAer treatment
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
  • How medical device companies are responding to abortion bans

RSS From Medical Design & Outsourcing

  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]
  • ResMed names Lucile Blaise as new Sleep & Respiratory Care leader
    Lucile Blaise will be the new president of ResMed’s Sleep & Respiratory Care business starting July 1, ResMed (NYSE: RMD) said today. She replaces Jim Hollingshead, who became president and CEO of Insulet (Nasdaq:PODD) on June 1. ResMed President and COO Rob Douglas is serving as interim president of the Sleep & Respiratory Care during… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS